Presents several commentaries about psychiatric practice in Australia and New Zealand. Response to an article on the training requirements of the Royal Australian and New Zealand College of Psychiatrists; Criticism against the product information on the drug Serzone/nefazodone which appeared in two mental health journals in August 1999.